Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 6792543, 10 pages
https://doi.org/10.1155/2017/6792543
Research Article

Fucoxanthin, a Marine Carotenoid, Attenuates β-Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells

1Ningbo Key Laboratory of Behavioral Neuroscience, Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo 315211, China
2Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Ningbo University, Ningbo 315211, China
3Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92037, USA

Correspondence should be addressed to Wei Cui; nc.ude.ubn@iewiuc and Shan He; nc.ude.ubn@nahseh

Received 28 February 2017; Revised 30 May 2017; Accepted 12 June 2017; Published 8 August 2017

Academic Editor: Andrea Tarozzi

Copyright © 2017 Jiajia Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Scheltens, K. Blennow, M. M. Breteler et al., “Alzheimer’s disease,” Lancet, vol. 388, no. 10043, pp. 505–517, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. W. L. Klein, “Synaptotoxic amyloid-beta oligomer: a molecular basis for the cause, diagnosis, and treatment of Alzheimer’s disease?” Journal of Alzheimer’s Disease, vol. 33, Supplement 1, pp. S49–S65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. T. Ferreira and W. L. Klein, “The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease,” Neurobiology of Learning and Memory, vol. 96, pp. 529–543, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Jimenez, M. Torres, M. Vizuete et al., “Age-dependent accumulation of soluble amyloid beta (Abeta) oligomer reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model,” The Journal of Biological Chemistry, vol. 286, pp. 18414–18425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. H. Chong, Y. J. Shin, E. O. Lee, R. Kayed, C. G. Glabe, and A. J. Tenner, “ERK1/2 activation mediates Aβ oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures,” The Journal of Biological Chemistry, vol. 281, pp. 20315–20325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Kim, J. Park, K. T. Chang, and D. S. Lee, “Peroxiredoxin 5 prevents amyloid-beta oligomer-induced neuronal cell death by inhibiting ERK-Drp1-mediated mitochondrial fragmentation,” Free Radical Biology and Medicine, vol. 90, pp. 184–194, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Gammone, G. Riccioni, and N. D'Orazio, “Marine carotenoids against oxidative stress: effects on human health,” Marine Drugs, vol. 13, pp. 6226–6246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Gammone and N. D'Orazio, “Anti-obesity activity of the marine carotenoid fucoxanthin,” Marine Drugs, vol. 13, pp. 2196–2214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Lin, L. Huang, J. Yu et al., “Fucoxanthin, a marine carotenoid, reverses scopolamine-induced cognitive impairments in mice and inhibits acetylcholinesterase in vitro,” Marine Drugs, vol. 14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Pangestuti, T. S. Vo, D. H. Ngo, and S. K. Kim, “Fucoxanthin ameliorates inflammation and oxidative reponses in microglia,” Journal of Agricultural and Food Chemistry, vol. 61, pp. 3876–3883, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Zhao, S. Zhang, C. An et al., “Neuroprotective effect of fucoxanthin on β-amyloid-induced cell death,” Journal of Chinese Pharmaceutical Sciences, vol. 24, pp. 467–474, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. H. A. Jung, M. Y. Ali, R. J. Choi, H. O. Jeong, H. Y. Chung, and J. S. Choi, “Kinetics and molecular docking studies of fucosterol and fucoxanthin, BACE1 inhibitors from brown algae Undaria pinnatifida and Ecklonia stolonifera,” Food and Chemical Toxicology, vol. 89, pp. 104–111, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Jiang, M. Huang, S. Xu et al., “Bis(propyl)-cognitin prevents beta-amyloid-induced memory deficits as well as synaptic formation and plasticity impairments via the activation of PI3-K pathway,” Molecular Neurobiology, vol. 53, pp. 3832–3841, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Wang, M. J. Rowan, and R. Anwyl, “Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide,” The Journal of Neuroscience, vol. 24, pp. 6049–6056, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Cui, Z. Zhang, W. Li et al., “The anti-cancer agent SU4312 unexpectedly protects against MPP+-induced neurotoxicity via selective and direct inhibition of neuronal NOS,” British Journal of Pharmacology, vol. 168, pp. 1201–1214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Cui, Z. J. Zhang, S. Q. Hu et al., “Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction,” CNS Neuroscience & Therapeutics, vol. 20, pp. 244–252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Yu, J. Zheng, J. Lin et al., “Indirubin-3-oxime prevents H2O2-induced neuronal apoptosis via concurrently inhibiting GSK3β and the ERK pathway,” Cellular and Molecular Neurobiology, vol. 37, no. 4, pp. 655–664, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Cui, Z. Zhang, W. Li et al., “Unexpected neuronal protection of SU5416 against 1-methyl-4-phenylpyridinium ion-induced toxicity via inhibiting neuronal nitric oxide synthase,” PLoS One, vol. 7, article e46253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Hu, R. Wang, W. Cui et al., “Inhibiting beta-amyloid-associated Alzheimer’s pathogenesis in vitro and in vivo by a multifunctional dimeric bis(12)-hupyridone derived from its natural analogue,” Journal of Molecular Neuroscience, vol. 55, no. 4, pp. 1014–1021, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Hu, W. Cui, Z. Zhang et al., “Indirubin-3-oxime effectively prevents 6OHDA-induced neurotoxicity in PC12 cells via activating MEF2D through the inhibition of GSK3beta,” Journal of Molecular Neuroscience, vol. 57, pp. 561–570, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Guo, C. Zheng, W. Cai et al., “Multifunction of chrysin in Parkinson’s model: anti-neuronal apoptosis, neuroprotection via activation of MEF2D, and inhibition of monoamine oxidase-B,” Journal of Agricultural and Food Chemistry, vol. 64, pp. 5324–5333, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Kayed and C. A. Lasagna-Reeves, “Molecular mechanisms of amyloid oligomer toxicity,” Journal of Alzheimer’s Disease, vol. 33, Supplement 1, pp. S67–S78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. Ryan, W. C. Narrow, H. J. Federoff, and W. J. Bowers, “An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies,” Journal of Neuroscience Methods, vol. 190, pp. 171–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Wang, D. M. Walsh, M. J. Rowan, D. J. Selkoe, and R. Anwyl, “Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5,” The Journal of Neuroscience, vol. 24, pp. 3370–3378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kim, K. S. Park, M. K. Kim, H. Choo, and Y. Chong, “Dicyanovinyl-substituted J147 analogue inhibits oligomerization and fibrillation of beta-amyloid peptides and protects neuronal cells from beta-amyloid-induced cytotoxicity,” Organic & Biomolecular Chemistry, vol. 13, pp. 9564–9569, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. R. T. Cameron, S. D. Quinn, L. S. Cairns et al., “The phosphorylation of Hsp20 enhances its association with amyloid-beta to increase protection against neuronal cell death,” Molecular and Cellular Neurosciences, vol. 61, pp. 46–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Heo and Y. J. Jeon, “Protective effect of fucoxanthin isolated from Sargassum siliquastrum on UV-B induced cell damage,” Journal of Photochemistry and Photobiology B, vol. 95, pp. 101–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Pangestuti and S. K. Kim, “Neuroprotective effects of marine algae,” Marine Drugs, vol. 9, pp. 803–818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K. N. Kim, S. J. Heo, W. J. Yoon et al., “Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-kappaB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages,” European Journal of Pharmacology, vol. 649, pp. 369–375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. H. Choi, N. H. Kim, S. J. Kim, H. J. Lee, and S. Kim, “Fucoxanthin inhibits the inflammation response in paw edema model through suppressing MAPKs, Akt, and NFkappaB,” Journal of Biochemical and Molecular Toxicology, vol. 30, pp. 111–119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Zheng, M. J. Piao, K. C. Kim, C. W. Yao, J. W. Cha, and J. W. Hyun, “Fucoxanthin enhances the level of reduced glutathione via the Nrf2-mediated pathway in human keratinocytes,” Marine Drugs, vol. 12, pp. 4214–4230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, pp. 239–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. M. Shi, Y. W. Han, X. H. Han et al., “Upstream regulators and downstream effectors of NF-kappa B in Alzheimer’s disease,” Journal of the Neurological Sciences, vol. 366, pp. 127–134, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. J. J. Lin, L. Huang, J. Yu et al., “Fucoxanthin, a marine carotenoid, reverses scopolamine-induced cognitive impairments in mice and inhibits acetylcholinesterase in vitro,” Marine Drugs, vol. 14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. H. R. Parri, C. M. Hernandez, and K. T. Dineley, “Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer’s disease,” Biochemical Pharmacology, vol. 82, pp. 931–942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. N. N. Nalivaeva and A. J. Turner, “AChE and the amyloid precursor protein (APP) - cross-talk in Alzheimer’s disease,” Chemico-Biological Interactions, vol. 259, pp. 301–306, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Russo, A. Del Bufalo, A. Frustaci, M. Fini, and A. Cesario, “Beyond acetylcholinesterase inhibitors for treating Alzheimer’s disease: alpha 7-nAChR agonists in human clinical trials,” Current Pharmaceutical Design, vol. 20, pp. 6014–6021, 2014. View at Publisher · View at Google Scholar
  38. C. Wan-Loy and P. Siew-Moi, “Marine algae as a potential source for anti-obesity agents,” Marine Drugs, vol. 14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Abidov, Z. Ramazanov, R. Seifulla, and S. Grachev, “The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat,” Diabetes, Obesity & Metabolism, vol. 12, pp. 72–81, 2010. View at Publisher · View at Google Scholar · View at Scopus